drugset / Trial / NCT00357097

The Effects Of Ropinirole On Mood Or Mild Depression In Patients With Moderate To Severe Restless Legs Syndrome

NCT00357097

Phase 3 Completed 240 enrolled GlaxoSmithKline
RandomizedParallel-groupTriple-blindTreatment

Summary

Ropinirole has shown to improve mood in depressed patients as well as to improve the symptoms of Restless Legs Syndrome. Up to 40% of RLS patients suffer from mild depression, therefore it would be important for decisions no therapy to know whether a drug could improve both depressive and RLS symptoms.

Timeline

Start
2006-06
Primary completion
2007-12
Completion
2007-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Ropinirole Small molecule